Eisai
4523.T
#2159
Rank
HK$72.69 B
Marketcap
HK$257.89
Share price
1.81%
Change (1 day)
15.83%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: HK$4.10 Billion

According to Eisai's latest financial reports the company's current earnings are HK$5.06 Billion. In 2023 the company made an earning of HK$4.10 Billion, an increase over its 2022 earnings that were of -HK$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023HK$4.10 B-2404.04%
2022-HK$0.18 Billion-103.6%
2021HK$4.94 B-39.81%
2020HK$8.22 B7.44%
2019HK$7.65 B17.22%
2018HK$6.52 B86.16%
2017HK$3.50 B-23.52%
2016HK$4.58 B26.97%
2015HK$3.61 B22.3%
2014HK$2.95 B-46.07%
2013HK$5.47 B-21.85%
2012HK$7.00 B-20.59%
2011HK$8.82 B-8.91%
2010HK$9.68 B19.21%
2009HK$8.12 B